2025
SJR Q3
JCR Q3 · 1,3
OA
3 matched articles
SCIE
Journal detail
Leprosy Review
- Publisher
- Lepra
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0305751821628807
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,295
- Quartile Q3
- H-Index 53
- Cites/doc 0,69
- Docs (3y) 154
- Cites (3y) 121
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,3
- 5Y JIF 1
- JCI 0,32
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q3
- Infectious Diseases Q3
- Medicine (miscellaneous) Q3
Areas
- Medicine
WoS categories
- Dermatology | Infectious Diseases | Pathology | Tropical Medicine
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,295 | 1,3 | 1 | 0,32 | Q4 | 53 |
| 2024 | Q3 | Q4 | 0,302 | 0,8 | 0,7 | 0,23 | Q4 | 52 |
| 2023 | Q3 | Q4 | 0,312 | 0,8 | 0,5 | 0,2 | Q4 | 52 |
| 2022 | Q3 | Q4 | 0,285 | 0,6 | 0,8 | 0,17 | Q4 | 52 |
| 2021 | Q3 | Q4 | 0,304 | 0,5 | 0,7 | 0,15 | Q4 | 52 |
| 2020 | Q3 | Q4 | 0,437 | 0,5 | 0,9 | 0,2 | Q4 | 52 |
| 2019 | Q3 | Q4 | 0,298 | 0,7 | 0,9 | 0,21 | Q4 | 52 |
| 2018 | — | Q4 | — | 0,5 | 1 | 0,22 | Q4 | — |
| 2017 | Q2 | Q4 | 0,563 | 0,8 | 1 | 0,28 | Q3 | 52 |
| 2016 | Q3 | Q4 | 0,208 | 0,8 | 1,1 | — | — | 52 |
| 2015 | Q3 | Q4 | 0,203 | 0,8 | 1,1 | — | — | 52 |
| 2014 | Q3 | Q4 | 0,204 | 0,7 | 0,9 | — | — | 52 |
| 2013 | Q3 | Q4 | 0,222 | 0,6 | 0,8 | — | — | 52 |
| 2012 | Q2 | Q3 | 0,563 | 0,9 | 1,2 | — | — | 52 |
| 2011 | Q2 | Q3 | 0,626 | 1 | 1,3 | — | — | 52 |
| 2010 | Q2 | Q3 | 0,585 | 1,2 | 1 | — | — | 52 |
| 2009 | — | Q3 | — | 1,2 | 1,3 | — | — | — |
| 2008 | — | Q3 | — | 1 | 1,1 | — | — | — |
| 2007 | — | Q2 | — | 1,3 | 1,2 | — | — | — |
| 2006 | — | Q4 | — | 0,8 | — | — | — | — |
| 2005 | — | Q3 | — | 0,8 | — | — | — | — |
| 2004 | — | Q3 | — | 0,8 | — | — | — | — |
| 2003 | — | Q2 | — | 0,9 | — | — | — | — |
| 2002 | — | Q2 | — | 1 | — | — | — | — |
| 2001 | — | Q2 | — | 0,7 | — | — | — | — |
| 2000 | — | Q2 | — | 1,3 | — | — | — | — |
| 1999 | — | Q2 | — | 1 | — | — | — | — |
| 1998 | — | Q2 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q3 | Q4 | 71/99 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 118/141 |
| 2025 | PATHOLOGY | SCIE | Q3 | Q4 | 64/89 |
| 2025 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 21/27 |
| 2024 | DERMATOLOGY | SCIE | Q4 | Q4 | 80/96 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 124/137 |
| 2024 | PATHOLOGY | SCIE | Q4 | Q4 | 77/90 |
| 2024 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 23/28 |
| 2023 | DERMATOLOGY | SCIE | Q4 | Q4 | 79/94 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 119/132 |
| 2023 | PATHOLOGY | SCIE | Q4 | Q4 | 75/88 |
| 2023 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 22/28 |
| 2022 | DERMATOLOGY | SCIE | Q4 | Q4 | 67/70 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 92/96 |
| 2022 | PATHOLOGY | SCIE | Q4 | Q4 | 73/76 |
| 2022 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 21/24 |
| 2021 | DERMATOLOGY | SCIE | Q4 | Q4 | 68/69 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 93/95 |
| 2021 | PATHOLOGY | SCIE | Q4 | Q4 | 75/77 |
| 2021 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 23/24 |
| 2020 | DERMATOLOGY | SCIE | Q4 | Q4 | 68/69 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 90/93 |
| 2020 | PATHOLOGY | SCIE | Q4 | Q4 | 74/77 |
| 2020 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 22/23 |
| 2019 | DERMATOLOGY | SCIE | Q4 | Q4 | 64/68 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 89/92 |
| 2019 | PATHOLOGY | SCIE | Q4 | Q4 | 70/78 |
| 2019 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 19/23 |
| 2018 | DERMATOLOGY | SCIE | Q4 | Q4 | 64/66 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 85/89 |
| 2018 | PATHOLOGY | SCIE | Q4 | Q4 | 69/76 |
| 2018 | TROPICAL MEDICINE | SCIE | Q4 | Q4 | 19/21 |
| 2017 | DERMATOLOGY | SCIE | Q4 | Q4 | 61/64 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 85/88 |
| 2017 | PATHOLOGY | SCIE | Q4 | Q4 | 70/79 |
| 2017 | TROPICAL MEDICINE | SCIE | Q4 | Q3 | 17/20 |
| 2016 | DERMATOLOGY | SCIE | Q4 | — | 57/63 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q4 | — | 80/84 |
| 2016 | PATHOLOGY | SCIE | Q4 | — | 68/79 |
| 2016 | TROPICAL MEDICINE | SCIE | Q4 | — | 15/19 |
| 2015 | DERMATOLOGY | SCIE | Q4 | — | 54/61 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q4 | — | 77/83 |
| 2015 | PATHOLOGY | SCIE | Q4 | — | 66/79 |
| 2015 | TROPICAL MEDICINE | SCIE | Q4 | — | 15/19 |
| 2014 | DERMATOLOGY | SCIE | Q4 | — | 58/63 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q4 | — | 76/78 |
| 2014 | PATHOLOGY | SCIE | Q4 | — | 70/76 |
| 2014 | TROPICAL MEDICINE | SCIE | Q4 | — | 17/20 |
| 2013 | DERMATOLOGY | SCIE | Q4 | — | 54/61 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q4 | — | 67/72 |
| 2013 | PATHOLOGY | SCIE | Q4 | — | 73/76 |
| 2013 | TROPICAL MEDICINE | SCIE | Q4 | — | 18/22 |
| 2012 | DERMATOLOGY | SCIE | Q4 | — | 45/59 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q4 | — | 65/70 |
| 2012 | PATHOLOGY | SCIE | Q4 | — | 67/77 |
| 2012 | TROPICAL MEDICINE | SCIE | Q3 | — | 15/22 |
| 2011 | DERMATOLOGY | SCIE | Q3 | — | 41/58 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q4 | — | 61/70 |
| 2011 | PATHOLOGY | SCIE | Q4 | — | 63/79 |
| 2011 | TROPICAL MEDICINE | SCIE | Q3 | — | 11/21 |
| 2010 | DERMATOLOGY | SCIE | Q3 | — | 39/55 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q4 | — | 50/58 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 55/76 |
| 2010 | TROPICAL MEDICINE | SCIE | Q3 | — | 10/19 |
| 2009 | DERMATOLOGY | SCIE | Q3 | — | 35/48 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q4 | — | 49/57 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 53/71 |
| 2009 | TROPICAL MEDICINE | SCIE | Q3 | — | 10/17 |
| 2008 | DERMATOLOGY | SCIE | Q4 | — | 38/43 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q4 | — | 47/51 |
| 2008 | PATHOLOGY | SCIE | Q4 | — | 59/69 |
| 2008 | TROPICAL MEDICINE | SCIE | Q3 | — | 10/15 |
| 2007 | DERMATOLOGY | SCIE | Q3 | — | 23/41 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q4 | — | 43/50 |
| 2007 | PATHOLOGY | SCIE | Q3 | — | 46/66 |
| 2007 | TROPICAL MEDICINE | SCIE | Q2 | — | 7/14 |
| 2006 | DERMATOLOGY | SCIE | Q4 | — | 34/39 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q4 | — | 44/47 |
| 2006 | PATHOLOGY | SCIE | Q4 | — | 52/64 |
| 2006 | TROPICAL MEDICINE | SCIE | Q4 | — | 9/11 |
| 2005 | DERMATOLOGY | SCIE | Q4 | — | 32/39 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q4 | — | 40/43 |
| 2005 | PATHOLOGY | SCIE | Q4 | — | 55/66 |
| 2005 | TROPICAL MEDICINE | SCIE | Q3 | — | 8/12 |
| 2004 | DERMATOLOGY | SCIE | Q3 | — | 26/38 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q4 | — | 39/41 |
| 2004 | PATHOLOGY | SCIE | Q4 | — | 52/65 |
| 2004 | TROPICAL MEDICINE | SCIE | Q3 | — | 6/11 |
| 2003 | DERMATOLOGY | SCIE | Q3 | — | 25/38 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q4 | — | 36/41 |
| 2003 | PATHOLOGY | SCIE | Q4 | — | 51/64 |
| 2003 | TROPICAL MEDICINE | SCIE | Q2 | — | 6/12 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 21/40 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q4 | — | 31/38 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 39/64 |
| 2002 | TROPICAL MEDICINE | SCIE | Q2 | — | 5/12 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 30/38 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q4 | — | 31/37 |
| 2001 | PATHOLOGY | SCIE | Q3 | — | 45/66 |
| 2001 | TROPICAL MEDICINE | SCIE | Q2 | — | 6/12 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 12/36 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q3 | — | 23/36 |
| 2000 | PATHOLOGY | SCIE | Q2 | — | 30/67 |
| 2000 | TROPICAL MEDICINE | SCIE | Q2 | — | 4/12 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 17/36 |
| 1999 | INFECTIOUS DISEASES | SCIE | Q3 | — | 24/35 |
| 1999 | PATHOLOGY | SCIE | Q3 | — | 39/66 |
| 1999 | TROPICAL MEDICINE | SCIE | Q2 | — | 6/12 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 19/35 |
| 1998 | INFECTIOUS DISEASES | SCIE | Q4 | — | 28/36 |
| 1998 | PATHOLOGY | SCIE | Q3 | — | 43/68 |
| 1998 | TROPICAL MEDICINE | SCIE | Q2 | — | 6/12 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 21/32 |
| 1997 | INFECTIOUS DISEASES | SCIE | Q4 | — | 27/34 |
| 1997 | PATHOLOGY | SCIE | Q4 | — | 52/66 |
| 1997 | TROPICAL MEDICINE | SCIE | Q3 | — | 10/16 |